3β,12β,14-Trihydroxy-11-oxo-5β-bufa-20,22-dienolide

• CAT Number: M086245
• CAS Number: 17008-65-0
• Molecular Formula: C24H32O6
• Molecular Weight: 416.51
• Purity: 98%
• Synonyms: Bufa-20,22-dienolide, 3,12,14-trihydroxy-11-oxo-, (3β,5β,12β)-
• Target: Apoptosis
• Storage: Store at -20°C
• IUPAC Name: 5-[(3S,5R,8R,9S,10S,12S,13S,14S,17R)-3,12,14-trihydroxy-10,13-dimethyl-11-oxo-2,3,4,5,6,7,8,9,12,15,16,17-dodecahydro-1H-cyclopenta[a]phenanthren-17-yl]pyran-2-one
• InChI: InChI=1S/C24H32O6/c1-22-9-7-15(25)11-14(22)4-5-17-19(22)20(27)21(28)23(2)16(8-10-24(17,23)29)13-3-6-18(26)30-12-13/h3,6,12,14-17,19,21,25,28-29H,4-5,7-11H2,1-2H3/t14-,15+,16-,17-,19-,21-,22+,23+,24+/m1/s1
• InChIKey: SOGONHOGEFLVPE-PUVOGLICSA-N
• SMILES: CC12CCC(CC1CCC3C2C(=O)C(C4(C3(CCC4C5=COC(=O)C=C5)O)C)O)O

3β,12β,14-Trihydroxy-11-oxo-5β-bufa-20,22-dienolide（Cat No.:M086245）is a high-purity bufadienolide compound essential in biochemical and pharmacological research. Known for its potent cardiotonic properties, it is used to study the mechanisms of cardiac glycosides and their effects on heart function. This compound also exhibits significant anticancer and anti-inflammatory activities, making it valuable for developing novel therapeutics. Its precise activity and structural specificity are crucial for advanced research into cell signaling pathways and disease treatment. This versatile compound is indispensable for advancing knowledge in cardiovascular and cancer research.